| Metabolic syndrome: updates on pathophysiology and management in 2021 G Fahed, L Aoun, M Bou Zerdan, S Allam, M Bou Zerdan, Y Bouferraa, ... International journal of molecular sciences 23 (2), 786, 2022 | 775 | 2022 |
| Triple negative breast cancer: updates on classification and treatment in 2021 M Bou Zerdan, T Ghorayeb, F Saliba, S Allam, M Bou Zerdan, M Yaghi, ... Cancers 14 (5), 1253, 2022 | 103 | 2022 |
| Mechanisms of immunotoxicity: stressors and evaluators M Bou Zerdan, S Moussa, A Atoui, HI Assi International Journal of Molecular Sciences 22 (15), 8242, 2021 | 35 | 2021 |
| Neurobrucellosis: brief review Y Bouferraa, MB Zerdan, R Hamouche, E Azar, C Afif, R Jabbour The neurologist 26 (6), 248-252, 2021 | 26 | 2021 |
| Adhesion molecules in multiple myeloma oncogenesis and targeted therapy M Bou Zerdan, L Nasr, J Kassab, L Saba, M Ghossein, M Yaghi, ... International Journal of Hematologic Oncology 11 (2), IJH39, 2022 | 23 | 2022 |
| Oligodendroglioma: a review of management and pathways M Bou Zerdan, HI Assi Frontiers in Molecular Neuroscience 14, 722396, 2021 | 22 | 2021 |
| Genomic assays in node positive breast cancer patients: a review M Bou Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi Frontiers in Oncology 10, 609100, 2021 | 18 | 2021 |
| Outcomes of patients with malignancy admitted to the intensive care units: a prospective study HI Assi, NA Halim, I Alameh, J Khoury, V Nahra, F Sukhon, ... Critical Care Research and Practice 2021 (1), 4792309, 2021 | 14 | 2021 |
| Systemic AL amyloidosis: current approach and future direction MB Zerdan, L Nasr, F Khalid, S Allam, Y Bouferraa, S Batool, M Tayyeb, ... Oncotarget 14, 384, 2023 | 12 | 2023 |
| Pathophysiology, clinical findings, and management of Fox‐Fordyce disease: A systematic review A Salloum, Y Bouferraa, N Bazzi, M Bou Zerdan, J Abi Chebl, T Chu, ... Journal of Cosmetic Dermatology 21 (2), 482-500, 2022 | 12 | 2022 |
| Fecal microbiota transplant for hematologic and oncologic diseases: principle and practice M Bou Zerdan, S Niforatos, S Nasr, D Nasr, M Ombada, S John, D Dutta, ... Cancers 14 (3), 691, 2022 | 12 | 2022 |
| The lung microbiota and lung cancer: a growing relationship M Bou Zerdan, J Kassab, P Meouchy, E Haroun, R Nehme, M Bou Zerdan, ... Cancers 14 (19), 4813, 2022 | 11 | 2022 |
| COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges S Moubarak, D Merheb, L Basbous, N Chamseddine, M Bou Zerdan, ... Journal of International Medical Research 50 (9), 03000605221125047, 2022 | 11 | 2022 |
| Role of circulating tumor DNA and circulating tumor cells in breast cancer: history and updates J Chedid, S Allam, N Chamseddine, M Bou Zerdan, C El Nakib, HI Assi SAGE Open Medicine 10, 20503121221077838, 2022 | 11 | 2022 |
| Molecular targets in salivary gland cancers: a comprehensive genomic analysis of 118 mucoepidermoid carcinoma tumors M Bou Zerdan, PA Kumar, D Zaccarini, J Ross, R Huang, ... Biomedicines 11 (2), 519, 2023 | 10 | 2023 |
| Radioimmunoconjugates in the age of modern immuno-oncology D Nasr, PA Kumar, MB Zerdan, G Ghelani, D Dutta, S Graziano, SH Lim Life Sciences 310, 121126, 2022 | 9 | 2022 |
| Recent advances in the treatment and supportive care of POEMS syndrome M Bou Zerdan, TI George, ST Bunting, CP Chaulagain Journal of Clinical Medicine 11 (23), 7011, 2022 | 7 | 2022 |
| Characterization and susceptibility of non-albicans Candida isolated from various clinical specimens in Lebanese hospitals R Husni, M Bou Zerdan, N Samaha, M Helou, Y Mahfouz, R Saniour, ... Frontiers in Public Health 11, 1115055, 2023 | 6 | 2023 |
| Latest updates on cellular and molecular biomarkers of gliomas M Bou Zerdan, A Atoui, A Hijazi, L Basbous, R Abou Zeidane, SM Alame, ... Frontiers in Oncology 12, 1030366, 2022 | 6 | 2022 |
| The gut microbiome and alzheimer’s disease: A growing relationship M Bou Zerdan, E Hebbo, A Hijazi, M El Gemayel, J Nasr, D Nasr, M Yaghi, ... Current Alzheimer Research 19 (12), 808-818, 2022 | 6 | 2022 |
Hazem AssiAssociate Professor, American University of Beirut在 aub.edu.lb 的电子邮件经过验证
